Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy
- Resource Type
- article
- Source
- Advanced Science, Vol 10, Iss 36, Pp n/a-n/a (2023)
- Subject
Science - Language
- English
- ISSN
- 2198-3844